Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biocontrol Ltd.

Division of C3J Therapeutics Inc./AmpliPhi BioSciences Corp.

Latest From Biocontrol Ltd.

Deals Shaping the Medical Industry (02/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • C3J Therapeutics Inc.
  • Senior Management
  • Edward C Cappabianca, CEO
    Tuula Moilanen, CFO
    David Scott, Commercial Dir.
    David Harper, MD, CSO
  • Contact Info
  • Biocontrol Ltd.
    Phone: 0845 680 0971
    Colworth Science Park
    Sharnbrook, MK44 1LQ